24 Apr2024
Bluefield Solar Income Fund – Fundamentals shine despite discount
24 Apr2024
Bluefield Solar Income Fund – Fundamentals shine despite discount
24 Apr2024
Bluefield Solar Income Fund – Fundamentals shine despite discount
23 Apr2024
HydrogenOne Capital Growth – Momentum building despite discount
23 Apr2024
HydrogenOne Capital Growth – Momentum building despite discount
NB Private Equity Partners says that over 2023 its NAV total return in dollars was 2.3%. A narrowing discount meant that the share price return was better (9.4% in sterling terms). However, over the first quarter of 2024 the NAV return was -1.4%, driven by declines in quoted holdings and foreign exchange headwinds. Dividends for […]
BioPharma Credit is lending $100m to Trasus Pharmaceuticals. BioPharma Credit Investments V will lend an additional $100m alongside this. Based in the US, Tarsus is a publicly traded biopharmaceutical company with a current market capitalisation of about $1.2bn (Ticker: TARS – NASDAQ). Tarsus currently markets XDEMVY® (lotilaner ophthalmic solution), a treatment for Demodex blepharitis. XDEMVY® […]
US Solar Fund is planning a fixed-price tender offer at $0.764 per share (equivalent to the 31 December 2023 NAV of $0.78 per share, less 2% for the costs of administering the tender offer). Shareholders may choose to tender for sale some or all of their shares, subject to an upper limit of $19m being […]
Martin Currie Global Portfolio managed to beat the return on the MSCI All Country World Index over the 12 months ended 31 January 2024, returning 11.2% to the index’s 10.9%. A stable discount (the result of its zero dividend discount mechanism) meant that the return to shareholders was 11.1%. The company declared dividends totaling 4.2p […]
In QuotedData’s morning briefing 24 April 2024: Apax Global Alpha (APAX) is investing about €8m (through its investment in Apax Digital II) into IANS, “a leading provider of tech-enabled research and advisory services in the information security industry”. The transaction is expected to close in Q2 2024. Octopus Renewables Infrastructure (ORIT) has signed a power […]
Hipgnosis Song Management, the investment advisor for Hipgnosis Songs Fund (SONG) has issued a statement regarding the recent issues surrounding the trust. It is outlined in full below. “Hipgnosis Songs Fund is a self-managed investment trust with multiple specialist advisers, appointed by the Company’s Board, to advise the Board in their respective areas of expertise […]
Ian Lance, co-manager of Temple Bar, had this to say: We note the statement from the Board of IDS confirming that on 9 April 2024 it received a preliminary and conditional non-binding proposal from EP Group regarding a possible cash offer for the entire issued and to be issued share capital of International Distribution Services […]
Marble Point Loan Financing (MPLF) has released its annual results for the 12 months ending 31 December 2023. Over the 12 month period MPLF’s ordinary share class returned a NAV total return of 17.5%, while its liquidating share class returned 18.3%. MPLF’s portfolio value fell from $145.5m to 118.4m, however this was due to dividend […]
Find out about investor events near you
A gateway to a library of useful information to help cut through the jargon
Sign up for our free equity research notes sent straight to your inbox
Access daily updated company fact sheets and peer group analysis tools
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
